4.6 Article

ZNF139/circZNF139 promotes cell proliferation, migration and invasion via activation of PI3K/AKT pathway in bladder cancer

Journal

AGING-US
Volume 12, Issue 10, Pages 9915-9934

Publisher

IMPACT JOURNALS LLC
DOI: 10.18632/aging.103256

Keywords

circular RNA; ZNF139; bladder cancer; PI3K/AKT signaling pathway; bioinformatics

Funding

  1. National Natural Science Foundation of China [81802541]

Ask authors/readers for more resources

Existing reports identify the involved roles of ZNF139 and its one circular RNA (circRNA), circZNF139, in the progression of various tumors. However, their relevance and function role in bladder cancer (BC) remain largely unexplored. Herein, we aimed to reconnoiter the role and potential mechanism of ZNF139 and circZNF139 in the progression of BC. Firstly, bioinformatics analyses indicated ZNF139 was upregulated in BC tissues and correlated with disease-free survival of BC patients. The subcellular localization and structural analyses of ZNF139 conveyed the possibility of ZNF139 functioning as a transcription factor. Secondly, circZNF139 was validated by bioinformatics analyses and RNase R tests. ZNF139 and circZNF139 were both significantly upregulated in BC cell lines. Functionally, ZNF139/circZNF139 had facilitated effects on the proliferative, clonal, migratory, and invasive potential of BC cells. Mechanistically, GO, KEGG pathway analyses and western blot assays altogether unveiled ZNF139/circZNF139 activated PI3K/AKT pathway in BC cells, supported by the alteration of AKT at phosphorylation level and PI3K at the protein level. Collectively, this work reveals ZNF139 and circZNF139 cooperate closely with each other to promote cell proliferation, migration and invasion via activation of PI3K/AKT pathway in BC.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Oncology

Effects of hub genes on the clinicopathological and prognostic features of lung adenocarcinoma

Dong-Hu Yu, Jing-Yu Huang, Xiao-Ping Liu, Xiao-Lan Ruan, Chen Chen, Wei-Dong Hu, Sheng Li

ONCOLOGY LETTERS (2020)

Article Biotechnology & Applied Microbiology

Screening and Functional Analysis of Hub MicroRNAs Related to Tumor Development in Colon Cancer

Dong-Hu Yu, Wei Li, Jing-Yu Huang, Xiao-Ping Liu, Chi Zhang, Xiao-Lan Ruan, Sheng Li

BIOMED RESEARCH INTERNATIONAL (2020)

Article Biotechnology & Applied Microbiology

Prognostic Factors Analysis and Nomogram Construction of Dual Primary Lung Cancer: A Population Study

Cong-kuan Song, Zi-xin Guo, Xiao-yan Shen, Yu-jin Wang, Qing-wen Wang, Dong-hu Yu, Chen Chen, Xiao-ping Liu, Jing-yu Huang, Sheng Li, Weidong Hu

BIOMED RESEARCH INTERNATIONAL (2020)

Article Oncology

Comprehensive Analysis of Competitive Endogenous RNAs Network, Being Associated With Esophageal Squamous Cell Carcinoma and Its Emerging Role in Head and Neck Squamous Cell Carcinoma

Donghu Yu, Xiaolan Ruan, Jingyu Huang, Weidong Hu, Chen Chen, Yu Xu, Jinxuan Hou, Sheng Li

FRONTIERS IN ONCOLOGY (2020)

Article Cell Biology

To construct a ceRNA regulatory network as prognostic biomarkers for bladder cancer

Jiazhi Jiang, Yaqiong Bi, Xiao-Ping Liu, Donghu Yu, Xin Yan, Jie Yao, Tongzu Liu, Sheng Li

JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2020)

Article Genetics & Heredity

Analysis of the Interaction Network of Hub miRNAs-Hub Genes, Being Involved in Idiopathic Pulmonary Fibers and Its Emerging Role in Non-small Cell Lung Cancer

Dong Hu Yu, Xiao-Lan Ruan, Jing-Yu Huang, Xiao-Ping Liu, Hao-Li Ma, Chen Chen, Wei-Dong Hu, Sheng Li

FRONTIERS IN GENETICS (2020)

Article Genetics & Heredity

Analysis of Expression and Its Clinical Significance of the Secreted Phosphoprotein 1 in Lung Adenocarcinoma

Zixin Guo, Jingyu Huang, Yujin Wang, Xiao-Ping Liu, Wei Li, Jie Yao, Sheng Li, Weidong Hu

FRONTIERS IN GENETICS (2020)

Article Biochemistry & Molecular Biology

A DNA Methylation-Based Panel for the Prognosis and Dagnosis of Patients With Breast Cancer and Its Mechanisms

Xiao-Ping Liu, Jinxuan Hou, Chen Chen, Li Guan, Han-Kun Hu, Sheng Li

FRONTIERS IN MOLECULAR BIOSCIENCES (2020)

Review Clinical Neurology

Methodological issues of systematic reviews and meta-analyses in the field of sleep medicine: A meta-epidemiological study

Chang Xu, Luis Furuya-Kanamori, Joey S. W. Kwong, Sheng Li, Yu Liu, Suhail A. Doi

Summary: An increasing number of systematic reviews and meta-analyses (SRMAs) have been published in the field of sleep medicine, but the methodological validity of these studies is poor, indicating a need for further improvement.

SLEEP MEDICINE REVIEWS (2021)

Article Cell Biology

A Combined Two-mRNA Signature Associated With PD-L1 and Tumor Mutational Burden for Prognosis of Lung Adenocarcinoma

Congkuan Song, Zhiquan Wu, Qingwen Wang, Yujin Wang, Zixin Guo, Sheng Li, Weidong Hu

Summary: A study identified two genes that can predict response to immunotherapy in lung adenocarcinoma patients, developed a signature to distinguish high- and low-risk patients, and constructed a nomogram by combining immune prognostic signature with clinical features.

FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2021)

Article Cell Biology

Dysregulation of miR-138-5p/RPS6KA1-AP2M1 Is Associated With Poor Prognosis in AML

Dong-Hu Yu, Chen Chen, Xiao-Ping Liu, Jie Yao, Sheng Li, Xiao-Lan Ruan

Summary: The interaction between FLT3-ITD mutation and the CXCL12/CXCR4 axis activates the PI3K-Akt-mTOR pathway, leading to increased expression of RPS6KA1 and AP2M1 in AML. These two genes regulate drug resistance in AML, while miR-138-5p serves as a common regulatory target for both RPS6KA1 and AP2M1.

FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2021)

Article Oncology

FAT3 Mutation Is Associated With Tumor Mutation Burden and Poor Prognosis in Esophageal Cancer

Zixin Guo, Xin Yan, Congkuan Song, Qingwen Wang, Yujin Wang, Xiao-Ping Liu, Jingyu Huang, Sheng Li, Weidong Hu

Summary: The study found that FAT3 mutation is related to high TMB and poor prognosis in ESCA patients. FAT3 mutation status may be an independent prognostic factor for ESCA patients. The research also revealed the potential mechanism of FAT3 mutation in the occurrence and development of ESCA.

FRONTIERS IN ONCOLOGY (2021)

Article Cell Biology

Identification and Validation of a Novel Prognosis Prediction Model in Adrenocortical Carcinoma by Integrative Bioinformatics Analysis, Statistics, and Machine Learning

Xin Yan, Zi-Xin Guo, Dong-Hu Yu, Chen Chen, Xiao-Ping Liu, Zhi-Wei Yang, Tong-Zu Liu, Sheng Li

Summary: This study established and validated a prognostic multi-gene model, identifying six prognostic biomarkers that may be useful for predicting the prognosis of ACC patients.

FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2021)

No Data Available